Antonio Benito Porcaro, Alberto Bianchi, Andrea Panunzio, Sebastian Gallina, Emanuele Serafin, Alessandro Tafuri, Nicolò Trabacchin, Rossella Orlando, Paola Irene Ornaghi, Giovanni Mazzucato, Stefano Vidiri, Damiano D'Aietti, Francesca Montanaro, Davide Brusa, Giulia Marafioti Patuzzo, Francesco Artoni, Alberto Baielli, Filippo Migliorini, Vincenzo De Marco, Alessandro Veccia, Matteo Brunelli, Salvatore Siracusano, Maria Angela Cerruto, Alessandro Antonelli
PURPOSE: We sought to investigate predictors of unfavorable tumor upgrading in very favorable intermediate-risk (IR) prostate cancer (PCa) patients treated with robot-assisted radical prostatectomy, in addition to evaluate how it may affect the risk of disease progression. METHODS: A very favorable subset of IR PCa patients presenting with prostate-specific antigen (PSA) < 10 ng/mL, percentage of biopsy positive cores (BPC) < 50%, and either International Society of Urological Pathology (ISUP) grade group 1 and clinical stage T2b or ISUP grade group 2 and clinical stage T1c-2b was identified...
March 30, 2024: International Urology and Nephrology